The Motley Fool

2 of the best cheap stocks to buy with £500 each

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Shopping cart with boxes labelled REITs, ETFs, Bonds, Stocks
Image source: Getty Images.

Plenty of top-quality stocks got washed out during the September sell-off. The investor exodus — sparked by concerns over a crashing Chinese property market and worsening supply chain problems — took no prisoners. Some of the best stocks to buy out there were sold along with the duds.

UK share prices have stabilised since then. But I wouldn’t be surprised to see further carnage on the London Stock Exchange. Covid-19 infections rates remain too high for comfort as the Delta variant runs freely. Rocketing inflation, and the threat of a rapid tightening of central bank policy, is also spooking investors. News that the International Monetary Fund has downgraded global growth forecasts hasn’t helped market confidence this week either.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

Why I’m still bargain hunting!

All that being said, I have no plans to stop shopping for UK shares. September’s sell-off gives me the chance to load up on the best stocks to buy at little extra cost. Some of them trade on P/E and PEG ratios that are so low they offer investors a wide margin for error should the global economy indeed grind to a halt too.

These two glorious UK shares are both on my radar. Here’s why I’d buy them for the long haul.

One of the best FTSE 100 stocks to buy 

I believe GlaxoSmithKline (LSE: GSK) could be one of the best value stocks to buy on the FTSE 100 right now. A forward P/E ratio of 13 times falls a little way below the index’s corresponding average. But it’s in the dividend arena where the pharma giant really makes a splash. Its yield for 2020 sits at a brilliant 5.5%.

Investing in drugs developers can often be risky business. Problems with medicine development and subsequent regulatory approval can cost companies a fortune in extra expenses and lost revenues. However, Glaxo’s terrific track record on this front makes me more confident here than I’d be with many of its rivals.

It’s also a market leader in many fast-growing therapy areas and its products have significant patent protection. As one of the world’s biggest medicine makers I expect profits here to soar as global healthcare spending booms.

Riding the cycling revolution

Halfords Group (LSE: HFD) has struggled to keep up with soaring bicycle demand from the early days of the pandemic. So it’s perhaps no surprise that the retailer’s share price tanked in September as concerns over supply chains worsened. I think now’s a great time to buy Halfords shares though, as today it trades on a rock-bottom forward P/E ratio of 10 times.

The average number of leisure rides jumped 75% in 2020, official data shows. And the popularity of cycling in the UK has remained strong, even as Covid-19 lockdowns have been rolled back. It’s a phenomenon that reflects the growing importance of healthy living and one which bodes well for the likes of Halfords.

What’s more, I expect demand for the store’s bicycles to receive a long-term boost as investment in cycle lanes and related infrastructure increases.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.